MoneyWorks4Me

The sales is pegged at Rs. 4929.60 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5916.30 millions during the year-ago period.The Net Profit of the company slipped to Rs. 269.10 millions from Rs. 395.40 millions, a decline of -31.94% on QoQ basis.The Operating Profit of the company witnessed a decrease to 543.30 millions from 725.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4929.60 5916.30 -16.68 4929.60 5916.30 -16.68 22669.10 24979.70 -9.25
Other Income 1.10 6.50 -83.08 1.10 6.50 -83.08 41.80 22.30 87.44
PBIDT 543.30 725.60 -25.12 543.30 725.60 -25.12 2703.10 2846.30 -5.03
Interest 74.60 77.70 -3.99 74.60 77.70 -3.99 301.60 325.30 -7.29
PBDT 468.70 647.90 -27.66 468.70 647.90 -27.66 2401.50 2521.00 -4.74
Depreciation 117.10 117.50 -0.34 117.10 117.50 -0.34 476.70 472.90 0.80
PBT 351.60 530.40 -33.71 351.60 530.40 -33.71 1924.80 2048.10 -6.02
TAX 82.50 135.00 -38.89 82.50 135.00 -38.89 506.00 520.00 -2.69
Deferred Tax 5.00 7.50 -33.33 5.00 7.50 -33.33 10.00 -12.50 -180.00
PAT 269.10 395.40 -31.94 269.10 395.40 -31.94 1418.80 1528.10 -7.15
Equity 919.40 926.00 -0.71 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 11.02 12.26 -10.14 11.02 12.26 -10.14 11.92 11.39 4.65

Aarti Drugs Share Price

417.60 -0.40 (-0.10%)
27-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.50
Dr. Reddys Labs. 1175.00
Cipla 1419.90
Lupin 2164.60
Zydus Lifesciences 1189.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: